HepQuant Presents a New Application for the HepQuant DuO™ Test: Improved Study Design and Treatment Monitoring in Clinical Trials

HepQuant, a leader in developing noninvasive, blood-based, quantitative testing to assess liver health, presented promising data utilizing the HepQuant DuO™ test to quantify liver function and physiology at an oral presentation on September 30, 2025 during the 9th Annual MASH Drug…

Go to Source